High prevalence of <i>ALPK3</i> premature terminating variants in Korean hypertrophic cardiomyopathy patientsopen access
- Authors
- Ryu, Seung Woo; Jeong, Won Chan; Hong, Geu Ru; Cho, Jung Sun; Lee, Soo Yong; Kim, Hyungseop; Jang, Jeong Yoon; Lee, Sun Hwa; Bae, Dae-Hwan; Cho, Jae Yeong; Kim, Ji Hee; Kim, Kyung-Hee; Son, Jang Won; Han, Beomman; Seo, Go Hun; Lee, Hane
- Issue Date
- Jul-2024
- Publisher
- FRONTIERS MEDIA SA
- Keywords
- ALPK3; premature terminating variant; hypertrophic cardiomyopathy; whole exome sequencing; Korean HCMP population
- Citation
- FRONTIERS IN CARDIOVASCULAR MEDICINE, v.11
- Indexed
- SCIE
SCOPUS
- Journal Title
- FRONTIERS IN CARDIOVASCULAR MEDICINE
- Volume
- 11
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/71805
- DOI
- 10.3389/fcvm.2024.1424551
- ISSN
- 2297-055X
- Abstract
- Background: The alpha-protein kinase 3 (ALPK3) gene (OMIM: 617608) is associated with autosomal recessive familial hypertrophic cardiomyopathy-27 (CMH27, OMIM: 618052). Recently, several studies have shown that monoallelic premature terminating variants (PTVs) in ALPK3 are associated with adult-onset autosomal dominant hypertrophic cardiomyopathy (HCMP). However, these studies were performed on patient cohorts mainly from European Caucasian backgrounds. Methods: To determine if this finding is replicated in the Korean HCMP cohort, we evaluated 2,366 Korean patients with non-syndromic HCMP using exome sequencing and compared the cohort dataset with three independent population databases. Results: We observed that monoallelic PTVs in ALPK3 were also significantly enriched in Korean patients with HCMP with an odds ratio score of 10-21. Conclusions: We suggest that ALPK3 PTV carriers be considered a risk group for developing HCMP and be monitored for cardiomyopathies.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.